Clinical Outcomes of Solid Organ Transplant Recipients Hospitalized with COVID-19: A Propensity Score-Matched Cohort Study
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background Solid-organ transplant recipients (SOTRs) receiving immunosuppressive therapy are expected to have worse clinical outcomes from coronavirus disease 2019 (COVID-19). However, published studies have shown mixed results, depending on adjustment for important confounders such as age, variants, and vaccination status. Materials and Methods We retrospectively collected the data on 7,327 patients hospitalized with COVID-19 from two tertiary hospitals with government-designated COVID-19 regional centers. We compared clinical outcomes between SOTRs and non-SOTRs by a propensity score-matched analysis (1:2) based on age, gender, and the date of COVID-19 diagnosis. We also performed a multivariate logistic regression analysis to adjust other important confounders such as vaccination status and the Charlson comorbidity index. Results After matching, SOTRs (n=83) had a significantly higher risk of high-flow nasal cannula use, mechanical ventilation, acute kidney injury, and a composite of COVID-19 severity outcomes than non-SOTRs (n=160) (all P <0.05). The National Early Warning Score was significantly higher in SOTRs than in non-SOTRs from day 1 to 7 of hospitalization (P for interaction=0.008 by generalized estimating equation). In multivariate logistic regression analysis, SOTRs (odds ratio [OR], 2.14; 95% confidence interval [CI], 1.12–4.11) and male gender (OR, 2.62; 95% CI, 1.26–5.45) were associated with worse outcomes, and receiving two to three doses of COVID-19 vaccine (OR, 0.43; 95% CI, 0.24–0.79) was associated with better outcomes. Conclusion Hospitalized SOTRs with COVID-19 had a worse prognosis than non-SOTRs. COVID-19 vaccination should be implemented appropriately to prevent severe COVID-19 progression in this population.
Abstract
Background Solid-organ transplant recipients (SOTRs) receiving immunosuppressive therapy are expected to have worse clinical outcomes from coronavirus disease 2019 (COVID-19). However, published studies have shown mixed results, depending on adjustment for important confounders such as age, variants, and vaccination status. Materials and Methods We retrospectively collected the data on 7,327 patients hospitalized with COVID-19 from two tertiary hospitals with government-designated COVID-19 regional centers. We compared clinical outcomes between SOTRs and non-SOTRs by a propensity score-matched analysis (1:2) based on age, gender, and the date of COVID-19 diagnosis. We also performed a multivariate logistic regression analysis to adjust other important confounders such as vaccination status and the Charlson comorbidity index. Results After matching, SOTRs (n=83) had a significantly higher risk of high-flow nasal cannula use, mechanical ventilation, acute kidney injury, and a composite of COVID-19 severity outcomes than non-SOTRs (n=160) (all P <0.05). The National Early Warning Score was significantly higher in SOTRs than in non-SOTRs from day 1 to 7 of hospitalization (P for interaction=0.008 by generalized estimating equation). In multivariate logistic regression analysis, SOTRs (odds ratio [OR], 2.14; 95% confidence interval [CI], 1.12–4.11) and male gender (OR, 2.62; 95% CI, 1.26–5.45) were associated with worse outcomes, and receiving two to three doses of COVID-19 vaccine (OR, 0.43; 95% CI, 0.24–0.79) was associated with better outcomes. Conclusion Hospitalized SOTRs with COVID-19 had a worse prognosis than non-SOTRs. COVID-19 vaccination should be implemented appropriately to prevent severe COVID-19 progression in this population.
참고문헌 (29)
- Gatti M, "Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population : a systematic review and meta-analysis", Clin Microbiol Infect, 28, pp.1057~1065 (2022)
- Andrews N, "Covid-19 vaccine effectiveness against the Omicron(B. 1. 1. 529)variant", N Engl J Med, 386, pp.1532~1546 (2022)
- Peters LL, "Association of COVID-19 vaccination with risk of COVID-19 infection, hospitalization, and death in heart transplant recipients", JAMA Cardiol, 7, pp.651~654 (2022)
- Ozturk S, "Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease : a nationwide analysis from Turkey", Nephrol Dial Transplant, 35, pp.2083~2095 (2020)
- Hall VG, "Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021 : a prospective, multicentre cohort study", CMAJ, 194, pp.E1155~E1163 (2022)
- Nimmo A, "The global impact of COVID-19 on solid organ transplantation : two years into a pandemic", Transplantation, 106, pp.1312~1329 (2022)
- Safa K, "COVID-19 vaccines and solid organ transplantation : more doses, more protection", Transplantation, 107, pp.21~22 (2023)
- Benotmane I, "Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine", Kidney Int, 99, pp.1498~1500 (2021)
- Marion O, "Safety and immunogenicity of anti-SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants", Ann Intern Med, 174, pp.1336~1338 (2021)
- Boyarsky BJ, "Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients", JAMA, 325, pp.2204~2206 (2021)
- Kang JM, "Matched versus mixed COVID-19 vaccinations in Korean solid organ transplant recipients : an observational study", Transplantation, 106, pp.e392~e403 (2022)
- Tang K, "Meta-analysis of immunologic response after COVID-19 mRNA vaccination in solid organ transplant recipients", J Infect, 84, pp.e73~e75 (2022)
- Thompson MG, "Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance-VISION Network, 10 States, August 2021-January 2022", MMWR Morb Mortal Wkly Rep, 71, pp.139~145 (2022)
- Lim JH, "Clinical effectiveness and safety of remdesivir in hemodialysis patients with COVID-19", Kidney Int Rep, 7, pp.2522~2525 (2022)
- Smith GB, "The ability of the National Early Warning Score(NEWS)to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death", Resuscitation, 84, pp.465~470 (2013)
- Khwaja A, "KDIGO clinical practice guidelines for acute kidney injury", Nephron Clin Pract, 120, pp.c179~c184 (2012)
- Kang JM, "COVID-19 among solid organ transplant recipients in Korea : surveillance data of the Korean Transplantation Society, January 2020 to March 2022", Korean J Transplant, 36, pp.159~163 (2022)
- Heldman MR, "COVID-19 in solid organ transplant recipients : a review of the current literature", Curr Treat Options Infect Dis, 13, pp.67~82 (2021)
- Colmenero J, "Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients", J Hepatol, 74, pp.148~155 (2021)
- Ravanan R, "SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England : A national cohort study", Am J Transplant, 20, pp.3008~3018 (2020)
- Khoury DS, "Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection", Nat Med, 27, pp.1205~1211 (2021)
- RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with Covid-19", N Engl J Med, 384, pp.693~704 (2021)
- Kalil AC, "Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study", Clin Infect Dis, 60, pp.216~222 (2015)
- Cremoni M, "Low T cell responsiveness in the early phase of COVID-19 associates with progression to severe pneumonia in kidney transplant recipients", Viruses, 14, pp.542~ (2022)
- Gabarre P, "Acute kidney injury in critically ill patients with COVID-19", Intensive Care Med, 46, pp.1339~1348 (2020)
- Lim JH, "Fatal outcomes of COVID-19 in patients with severe acute kidney injury", J Clin Med, 9, pp.1718~ (2020)
- Molnar MZ, "Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States", Am J Transplant, 20, pp.3061~3071 (2020)
- Goel RR, "mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern", Science, 374, pp.abm0829~ (2021)
- Li J, "Factors associated with COVID-19 vaccine response in transplant recipients : a systematic review and meta-analysis", Transplantation, 106, pp.2068~2075 (2022)